Annual SG&A
$1.54 B
+$94.64 M+6.54%
31 December 2022
Summary:
Horizon Therapeutics Public Limited annual selling, general & administrative expenses is currently $1.54 billion, with the most recent change of +$94.64 million (+6.54%) on 31 December 2022. During the last 3 years, it has risen by +$567.83 million (+58.34%). HZNP annual SG&A is now at all-time high.HZNP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$434.13 M
-$19.23 M-4.24%
30 June 2023
Summary:
Horizon Therapeutics Public Limited quarterly selling, general & administrative expenses is currently $434.13 million, with the most recent change of -$19.23 million (-4.24%) on 30 June 2023. HZNP quarterly SG&A is now -4.24% below its all-time high of $453.35 million, reached on 31 March 2023.HZNP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$2.61 B
+$187.92 M+7.75%
30 June 2023
Summary:
Horizon Therapeutics Public Limited TTM selling, general & administrative expenses is currently $2.61 billion, with the most recent change of +$187.92 million (+7.75%) on 30 June 2023. HZNP TTM SG&A is now at all-time high.HZNP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HZNP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +58.3% | +20.5% | +97.3% |
| 5 y5 years | +122.5% | +151.9% | +280.7% |
HZNP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +58.3% | -4.2% | +20.5% | at high | +542.2% |
| 5 y | 5 years | at high | +122.5% | -4.2% | +151.9% | at high | +154.4% |
| alltime | all time | at high | >+9999.0% | -4.2% | >+9999.0% | at high | +147.4% |
Horizon Therapeutics Public Limited Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $434.13 M(-4.2%) | $1.66 B(+2.2%) |
| Mar 2023 | - | $453.35 M(+21.7%) | $1.62 B(+5.2%) |
| Dec 2022 | $1.54 B(+6.5%) | $372.53 M(-6.3%) | $1.54 B(-1.7%) |
| Sept 2022 | - | $397.56 M(-0.2%) | $1.57 B(+2.4%) |
| June 2022 | - | $398.22 M(+6.8%) | $1.53 B(+2.9%) |
| Mar 2022 | - | $372.73 M(-6.6%) | $1.49 B(+2.8%) |
| Dec 2021 | $1.45 B(+48.6%) | $398.95 M(+10.7%) | $1.45 B(+9.2%) |
| Sept 2021 | - | $360.26 M(+1.4%) | $1.32 B(+11.3%) |
| June 2021 | - | $355.20 M(+7.0%) | $1.19 B(+12.6%) |
| Mar 2021 | - | $331.99 M(+19.9%) | $1.06 B(+8.7%) |
| Dec 2020 | $973.23 M(+39.6%) | $276.96 M(+22.5%) | $973.23 M(+10.4%) |
| Sept 2020 | - | $226.16 M(+1.7%) | $881.66 M(+6.5%) |
| June 2020 | - | $222.33 M(-10.3%) | $827.82 M(+7.1%) |
| Mar 2020 | - | $247.78 M(+33.6%) | $772.59 M(+10.8%) |
| Dec 2019 | $697.11 M(+0.7%) | $185.39 M(+7.6%) | $697.11 M(+1.6%) |
| Sept 2019 | - | $172.33 M(+3.1%) | $686.35 M(+1.6%) |
| June 2019 | - | $167.09 M(-3.0%) | $675.61 M(-1.4%) |
| Mar 2019 | - | $172.30 M(-1.3%) | $685.18 M(-1.1%) |
| Dec 2018 | $692.49 M(+5.7%) | $174.63 M(+8.1%) | $692.49 M(+1.1%) |
| Sept 2018 | - | $161.59 M(-8.5%) | $685.28 M(+1.1%) |
| June 2018 | - | $176.67 M(-1.6%) | $677.65 M(+2.6%) |
| Mar 2018 | - | $179.60 M(+7.3%) | $660.63 M(+0.8%) |
| Dec 2017 | $655.09 M(+8.6%) | $167.42 M(+8.8%) | $655.09 M(-4.1%) |
| Sept 2017 | - | $153.95 M(-3.6%) | $683.15 M(+3.3%) |
| June 2017 | - | $159.65 M(-8.3%) | $661.25 M(+4.1%) |
| Mar 2017 | - | $174.06 M(-11.0%) | $635.17 M(+5.3%) |
| Dec 2016 | $603.05 M | $195.49 M(+48.0%) | $603.05 M(+13.2%) |
| Sept 2016 | - | $132.05 M(-1.1%) | $532.79 M(+5.0%) |
| June 2016 | - | $133.57 M(-5.9%) | $507.23 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $141.94 M(+13.3%) | $508.90 M(+15.6%) |
| Dec 2015 | $440.31 M(+110.4%) | $125.23 M(+17.6%) | $440.31 M(+18.9%) |
| Sept 2015 | - | $106.49 M(-21.3%) | $370.40 M(+11.2%) |
| June 2015 | - | $135.25 M(+84.4%) | $333.13 M(+37.3%) |
| Mar 2015 | - | $73.34 M(+32.6%) | $242.69 M(+16.0%) |
| Dec 2014 | $209.23 M(+127.0%) | $55.32 M(-20.1%) | $209.23 M(+15.2%) |
| Sept 2014 | - | $69.22 M(+54.5%) | $181.60 M(+35.6%) |
| June 2014 | - | $44.81 M(+12.3%) | $133.88 M(+20.9%) |
| Mar 2014 | - | $39.89 M(+44.1%) | $110.78 M(+20.2%) |
| Dec 2013 | $92.16 M(+33.6%) | $27.69 M(+28.8%) | $92.16 M(+9.0%) |
| Sept 2013 | - | $21.50 M(-1.0%) | $84.58 M(+4.8%) |
| June 2013 | - | $21.71 M(+2.1%) | $80.71 M(+8.9%) |
| Mar 2013 | - | $21.27 M(+5.8%) | $74.10 M(+7.4%) |
| Dec 2012 | $69.00 M(+95.4%) | $20.10 M(+14.0%) | $69.00 M(+4.3%) |
| Sept 2012 | - | $17.63 M(+16.8%) | $66.16 M(+14.3%) |
| June 2012 | - | $15.10 M(-6.7%) | $57.86 M(+22.4%) |
| Mar 2012 | - | $16.18 M(-6.3%) | $47.28 M(+33.9%) |
| Dec 2011 | $35.32 M(+46.1%) | $17.26 M(+84.9%) | $35.32 M(+44.5%) |
| Sept 2011 | - | $9.33 M(+106.6%) | $24.44 M(+16.7%) |
| June 2011 | - | $4.52 M(+7.2%) | $20.94 M(-11.3%) |
| Mar 2011 | - | $4.21 M(-33.9%) | $23.61 M(-2.4%) |
| Dec 2010 | $24.17 M(+206.1%) | $6.37 M(+9.2%) | $24.19 M(+22.0%) |
| Sept 2010 | - | $5.83 M(-18.9%) | $19.83 M(+23.9%) |
| June 2010 | - | $7.19 M(+50.1%) | $16.00 M(+46.4%) |
| Mar 2010 | - | $4.79 M(+138.5%) | $10.93 M(+38.5%) |
| Dec 2009 | $7.89 M(+72.7%) | $2.01 M(-0.1%) | $7.89 M(+34.1%) |
| Sept 2009 | - | $2.01 M(-5.1%) | $5.89 M(+51.9%) |
| June 2009 | - | $2.12 M(+20.9%) | $3.87 M(+120.9%) |
| Mar 2009 | - | $1.75 M | $1.75 M |
| Dec 2008 | $4.57 M | - | - |
FAQ
- What is Horizon Therapeutics Public Limited annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Horizon Therapeutics Public Limited?
What is Horizon Therapeutics Public Limited annual selling, general & administrative expenses?
The current annual SG&A of HZNP is $1.54 B
What is the all time high annual SG&A for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual selling, general & administrative expenses is $1.54 B
What is Horizon Therapeutics Public Limited quarterly selling, general & administrative expenses?
The current quarterly SG&A of HZNP is $434.13 M
What is the all time high quarterly SG&A for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly selling, general & administrative expenses is $453.35 M
What is Horizon Therapeutics Public Limited TTM selling, general & administrative expenses?
The current TTM SG&A of HZNP is $2.61 B
What is the all time high TTM SG&A for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM selling, general & administrative expenses is $1.66 B